ArticleFrontiers in oncology2018

Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide.

Alessia Lo Dico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.